These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3884807

  • 1. Prazosin treatment of Raynaud's phenomenon: a double blind single crossover study.
    Russell IJ, Lessard JA.
    J Rheumatol; 1985 Feb; 12(1):94-8. PubMed ID: 3884807
    [Abstract] [Full Text] [Related]

  • 2. A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.
    Surwit RS, Gilgor RS, Allen LM, Duvic M.
    Arch Dermatol; 1984 Mar; 120(3):329-31. PubMed ID: 6367665
    [Abstract] [Full Text] [Related]

  • 3. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM, Korn JH, Csuka ME, Medsger TA, Rothfield NF, Ellman M, Martin R, Collier DH, Weinstein A, Furst DE, Jimenez SA, Mayes MD, Merkel PA, Gruber B, Kaufman L, Varga J, Bell P, Kern J, Marrott P, White B, Simms RW, Phillips AC, Seibold JR.
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Controlled study of nifedipine in the treatment of Raynaud's phenomenon].
    Kahan A, Weber S, Amor B, Saporta L, Hodara M, Degeorges M.
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):337-43. PubMed ID: 6285445
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prazosin treatment of primary Raynaud's phenomenon.
    Nielsen SL, Vitting K, Rasmussen K.
    Eur J Clin Pharmacol; 1983 Apr; 24(3):421-3. PubMed ID: 6345178
    [Abstract] [Full Text] [Related]

  • 8. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM, Malamet R, Wise RA.
    J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
    [Abstract] [Full Text] [Related]

  • 9. DIAS rounds. Nifedipine and prazosin in Raynaud's phenomenon.
    Pisenti L, Hart LL.
    Drug Intell Clin Pharm; 1984 Mar; 18(3):213-4. PubMed ID: 6365494
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R, Shariat K, von Wilmowsky H, Böhm M.
    Circulation; 2005 Nov 08; 112(19):2980-5. PubMed ID: 16275885
    [Abstract] [Full Text] [Related]

  • 12. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases.
    Kahan A, Weber S, Amor B, Menkes CJ, Hodara M, Degeorges M.
    Int Angiol; 1985 Nov 08; 4(2):221-3. PubMed ID: 3831143
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study.
    Arneklo-Nobin B, Elmér O, Akesson A.
    Int Angiol; 1988 Nov 08; 7(1):19-25. PubMed ID: 3290356
    [Abstract] [Full Text] [Related]

  • 20. Controlled multicenter double blind trial of an oral analog of prostacyclin in the treatment of primary Raynaud's phenomenon. French Microcirculation Society Multicentre Group for the Study of Vascular Acrosyndromes.
    Vayssairat M.
    J Rheumatol; 1996 Nov 08; 23(11):1917-20. PubMed ID: 8923366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.